Amanda Samuels
Director, Brand Access
专长:
Amanda Samuels leads our Brand Access products, which includes insights solutions to support client’s brand strategies. She helps clients assess the current and future access environments for their market, as well as identify opportunities to differentiate versus competitors.
Since joining EVERSANA in 2012, Amanda has developed an expertise in disease category management and brand access analysis. She tracks the access environment across multiple therapeutic areas, including but not limited to autoimmune, oncology, and rare diseases.
Prior to Amanda’s brand access work, she led the analytics and client service support for various syndicated solutions, focusing on leading health plans and marketplace trends, as well as biopharmaceutical company relationships with managed care organizations.
Amanda received her BS in Statistics from The College of New Jersey.
Articles by Amanda Samuels
The Influx of Generic Launches Leaves Narrow Opportunities for Multiple Sclerosis Access
Since the launch of Sandoz’s Glatopa in June 2015, generic options have slowly entered the multiple sclerosis market, providing some cost relief to payers in this high-cost market. Generic entrants, along with rising costs and a perceived lack of differentiation among brands on key clinical outcomes, solidify multiple sclerosis as one of the most extensively […]